As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months.  All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations.  It is required that disclosure be provided to the learners prior to the start of the activity.  Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist.  Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.  Disclosure in no way implies that the information presented is biased or of lesser quality.  It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations.  Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.

All identified conflicts of interest have been resolved.

The individuals listed below disclose the following financial relationships:

Noam A. Cohen MD, PhD – Speaker

Investigator – Pershing Square Foundation, RLG Foudnation

Consultant – GSK/Novartis, Bayer Health

Peer review competitive research – NIDCD

Founding Partner – 4 Sinuses LLC

Research – GeneOne Life Sciences

Richard L. Gallo MD, PhD – Speaker

Consultant – MatriSys Bioscience, Sente Inc.

Co-founder – MatriSys Bioscience

Independent Contractor – Regeneron

Jordan Orange, MD, PhD – Speaker

Consultant – Shire, CSL Behring

Speaker – Shire

Advisory Board Member – ADMA

Author - UptoDate

Michael Schatz, MD, MS – Speaker

Research grant – Merck, GlaxoSmithKline, AstraZeneca

Katharine M. Woessner, MD – Speaker

Speaker – Shire, Teva

Advisory Board Member - Shire

Bruce Zuraw, MD – Speaker

Consultant – CSL Behring, Shire, Adverum, Biocryst, Novartis

Jennifer Namazy, MD – Planner, Moderator, Reviewer

Advisory Board – Genentech; Consultant – GlaxoSmithKline

Warner Carr, MD – Planner, Moderator

Consultant – AstraZeneca, Boehringer Ingelheim, Meda, Regeneron, Sanofi, Teva; Speaker – AstraZeneca, Boehringer Ingelheim, Regeneron, Sanofi, Teva

Travis Miller, MD – Planner, Moderator

Advisor – Aimmune, Boston Scientific, Credit Suisse, DBV, Kaleo, Genentech, Optinose, Teva; Speaker – ALK, AstraZeneca, Genentech

Andrew White, MD – Planner

Speaker – AstraZeneca; Advisory Board Member – AstraZeneca

The following have no relevant financial relationships to disclose:

Catherine Lozupone, PhD – Speaker

David B. Peden, MD, MS – Speaker

Scott H. Sicherer, MD – Speaker

Donata Vercelli, MD – Speaker

Matthew Bowdish, MD – Planner, Moderator

Karol Anderson – Planner

Rene Anderson-Cowell, MD – Planner

David Elkayam, MD – Planner

Steve Machtinger, MD – Planner